$982,669,952 in Total Settlement Funds Available. See if you qualify!Find Out More

Novavax, Inc. Settlement
(NASDAQ: NVAX)
Settlement

Claim Deadline: May 18, 2024

Settlement Fund: $47,000,000

Settlement Class

All persons or entities that purchased or otherwise acquired the publicly traded common stock of Novavax, Inc. (“Novavax” or the “Company”) during the period from May 11, 2021 through October 19, 2021, inclusive

Important Documents

Settlement Status

Final Approval

Class Period

May 11, 2021 - January 14, 2022

Settlement Hearing Date

May 23, 2024

Opt-Out Deadline

May 02, 2024

Claims Admin

Strategic Claims Services
Novavax, Inc. Securities Settlement
c/o Strategic Claims Services, Inc.
600 N. Jackson Street, Suite 205
P.O. Box 230
Media, PA 19063
+1 400-4__-____
info@strategicclaims.net

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.